Clinical trial
Aspirin for the Treatment of Vascular Dysfunction After Preeclampsia
NCT06168461 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aspirin for the Treatment of Vascular Dysfunction After Preeclampsia
- Lead sponsor
- Anna Stanhewicz, PhD
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- November 1, 2023
- Completion date
- June 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preeclampsia